ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Lung Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Adenocarcinoma

Colon Cancer trials near Hanyang, Seoul, KOR:

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer (AZUR-2)

(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...

Enrolling
Colonic Neoplasms
Neoplasms, Colon
Drug: CAPEOX
Biological: Dostarlimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Seoul, Korea, Republic of and 250 other locations

dehydrogenase 1 (IDH1) arginine 132 (R132)-mutant advanced solid tumors, including but not limited to cholangiocarcinoma, chondrosarcoma, an...

Active, not recruiting
Any Solid Tumor
Glioma
Drug: LY3410738
Drug: Gemcitabine

Phase 1

Lilly
Lilly

Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 32 other locations

To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low a...

Active, not recruiting
Benign or Malignant Rectal or Colon Tumors
Colorectal Cancer
Device: Robotic Assisted Surgery
Intuitive Surgical
Intuitive Surgical

Seoul, Gangseo-gu, Korea, Republic of and 8 other locations

This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor ...

Enrolling
Any Solid Tumor
Colon Cancer
Drug: LOXO-292

Phase 1, Phase 2

Loxo Oncology
Loxo Oncology

Seoul, Korea, Republic of and 83 other locations

randomized studies focusing on wound infection rates and cost competitiveness between skin stapling devices and tissue adhesives in colorectal cancer...

Invitation-only
Colorectal Cancer
Surgical Site Infection
Device: skin bond
Device: skin stapler
Yoon Suk Lee

Seoul, Seocho, Korea, Republic of

oral LOXO-292 in pediatric participants with an activating rearranged during transfection (RET) alteration and an advanced solid or primary CNS tumor...

Enrolling
Papillary Thyroid Cancer
Medullary Thyroid Cancer
Drug: LOXO-292

Phase 1, Phase 2

Loxo Oncology
Loxo Oncology

Seoul, Seoul, Korea, Korea, Republic of and 25 other locations

Prospective, open label, multi-dose, sequential dose escalation, single-center, Phase 1 trial

Enrolling
Solid Tumor
Cancer
Drug: GB104(Level 3)
Drug: GB104(Level 2)

Phase 1

GI Biome

Seoul, Gangnam-gu, Korea, Republic of

inhibitor) monotherapy in adult subjects with advanced solid tumors and to identify the maximum tolerated dose (MTD), and the recommended Ph...

Active, not recruiting
Colorectal Cancer (CRC)
Advanced Solid Tumor
Drug: RMC-6291

Phase 1

Revolution Medicines
Revolution Medicines

Seoul, Korea, Republic of and 63 other locations

known as MVC-101) in adults with unremovable advanced or metastatic cancer. Another aim is to characterize and evaluate the activity of TAK-...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Squamous Cell Cancer of Head and Neck (SCCHN)
Drug: TAK-186

Phase 1, Phase 2

Takeda
Takeda

Seoul, Korea, Republic of and 19 other locations

pembrolizumab or irinotecan that can be given to patients who have cancers with specific molecular alterations called MSIhi (Microsatellite ...

Enrolling
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
Biological: pembrolizumab
Drug: HRO761

Phase 1

Novartis
Novartis

Seoul, Korea, Republic of and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems